Identification of EGFR mutations in type II papillary renal cell carcinoma-Reference-Cited by-同舟云学术

Identification of EGFR mutations in type II papillary renal cell carcinoma

Published:2023 Issue:3 Volume:6 Page:457-460
ISSN:2590-3233
Container-title:Cancer Research, Statistics, and Treatment
language:en
Short-container-title:

Author:

Jha Prerana¹,Trivedi Vaishakhi¹,Mishra Rohit¹,Chandrani Pratik²³⁴,Venkatakrishnan Radhika¹,Ramachandran Venkataramanan¹,Shah Minit⁵,Choughule Anuradha²³,Prabhash Kumar³⁵,Kumar Prashant¹,Noronha Vanita⁵

Affiliation:

1. Karkinos Healthcare Pvt Ltd, Navi Mumbai, Maharashtra, India

2. Medical Oncology – Molecular Laboratory, Tata Memorial Hospital, Mumbai, Maharashtra, India

3. Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai, Maharashtra, India

4. Center for Computational Biology, Bioinformatics and Crosstalk Lab, Advanced Centre for Treatment, Research, and Education in Cancer, Kharghar, Navi Mumbai, Maharashtra, India

5. Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India

Publisher

Medknow

Subject

Cancer Research,Oncology (nursing),Drug Guides,Oncology

Reference18 articles.

1. Cabozantinib:A narrative drug review;Srigadha;Cancer Res Stat Treat,2023

2. A rare EGFR mutation L747P conferred therapeutic efficacy to both gefitinib and osimertinib:A case report;Huang;Lung Cancer,2020

3. Exon-19 L747P mutation presented as a primary resistance to EGFR-TKI:A case report;Wang;J Thorac Dis,2016

4. Impact of concurrent genomic alterations in epidermal growth factor receptor (EGFR)-mutated lung cancer;Gini;J Thorac Dis,2020

5. Standards and guidelines for the interpretation and reporting of sequence variants in cancer:A joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists;Li;J Mol Diagn,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bevacizumab/cabozantinib/erlotinib;Reactions Weekly;2023-11-04